首页> 外文期刊>Free radical research >Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells
【24h】

Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells

机译:姜黄素及其合成类似物二甲氧基杂菌蛋白差异调节正常人周围血液单核细胞的抗氧化状态

获取原文
获取原文并翻译 | 示例
           

摘要

Curcumin is a polyphenol derived from the herb Curcuma longa, which has been extensively studied in terms of its antitumour, antioxidant, and chemopreventive activity as well as various other effects. In the present work we compared curcumin with its synthetic analogue dimethoxycurcumin (dimc) in terms of its antioxidant enzyme-modulating effects in human peripheral blood mononuclear cells (PBMC). We found that these compounds modulate antioxidant enzymes differentially. Both curcumin and dimethoxycurcumin effected a decrease in lipid peroxidation status in PBMC, however, curcumin had better activity in this regard. An increase in the activity of catalase was seen in the case of curcumin-treated PBMC, whereas dimc increased catalase activity significantly to almost twofold level. Real time-polymerase chain reaction (RT-PCR) analysis revealed significant up-regulation of catalase at mRNA level post treatment with curcumin as well as dimc, however, dimc had better activity in this regard. Glutathione reductase (GR) activity and reduced glutathione levels increased in the case of peripheral blood mononuclear cells (PBMC) treated with curcumin, however, the trend was reversed with dimethoxycurcumin where, both glutathione reductase activity and reduced glutathione levels were significantly reduced. RT-PCR analysis of glutathione reductase mRNA levels showed decrease in mRNA levels post treatment with dimethoxycurcumin (dimc) further corroborating GR enzyme assay results, however, we could not obtain significant result post curcumin treatment. NFkB reporter assay and western blot analysis of nuclear as well as cytosolic fractions of NFkB revealed that curcumin inhibits NFkB activation whereas inhibition was much less with dimc. It has been reported that curcumin and dimc exerts differential cytotoxicity in normal and tumour cells and the reason for this had been attributed to the differential uptake of these compounds by normal cells and tumour cells. Based on our results we propose that differential modulation of antioxidant enzymes via NFkB pathway could be the reason behind differential cytotoxicity of dimc as well as curcumin in normal cells and tumour cells in addition to differential uptake of these compounds as reported previously. ?2018 Informa UK Limited, trading as Taylor & Francis Group.
机译:姜黄素是衍生自草本莪术Longa的多酚,其已经在其抗肿瘤,抗氧化剂和化学预防活性以及各种其他效果方面广泛地研究。在本作工作中,我们将姜黄素与其合成的类似物二甲氧基核(DIMC)与其在人外周血单核细胞(PBMC)中的抗氧化酶调制作用进行比较。我们发现这些化合物调节抗氧化酶差异。姜黄素和二甲氧基杂菌蛋白在PBMC中的脂质过氧化状态的降低,然而,姜黄素在这方面具有更好的活性。在姜黄素处理的PBMC的情况下可以看到过氧化氢酶活性的增加,而DIMC显着增加过氧化氢酶活性至几乎两倍。实时 - 聚合酶链反应(RT-PCR)分析显示,用姜黄素以及DIMC的mRNA水平治疗的过氧化氢酶的显着上调,但DIMC在这方面有更好的活动。在用姜黄素处理的外周血单核细胞(PBMC)的情况下,谷胱甘肽还原酶(GR)活性和降低的谷胱甘肽水平增加,然而,用二甲氧基杂菌蛋白逆转,其中谷胱甘肽还原酶活性和降低的谷胱甘肽水平显着降低。 RT-PCR分析谷胱甘肽还原酶mRNA水平显示MRNA水平的降低,用二甲氧基官(DIMC)进一步证实GR酶测定结果,然而,我们无法获得姜黄素治疗后的显着结果。 NFKB记者测定和核的蛋白质印迹分析以及NFKB的细胞溶质级分显示,姜黄素抑制NFKB活化,而抑制则用DIMC抑制得多。据报道,姜黄素和DIMC在正常和肿瘤细胞中施加差异细胞毒性,其原因已归因于正常细胞和肿瘤细胞的这些化合物的差异吸收。基于我们的结果,我们提出通过NFKB途径的抗氧化酶的差异调制可以是DIMC差异细胞毒性的原因,并且除了如前所述这些化合物的差异摄取的差异中,姜黄素和肿瘤细胞之外。 ?2018年Informa UK Limited,贸易为泰勒和弗朗西斯集团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号